Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MSCI Inc. Director's Dealing 2026

Jan 28, 2026

30048_dirs_2026-01-28_abdc16f4-701e-4ab8-a41e-1ae89b9b6b80.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MSCI Inc. (MSCI)
CIK: 0001408198
Period of Report: 2026-01-26

Reporting Person: Fernandez Henry A (Director, Chairman and CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-01-26 Option to purchase common stock $554.52 A 42193 Acquired 2033-02-02 Common Stock (42193) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1487047 Direct
Common Stock 309821 Indirect
Common Stock 335069 Indirect
Common Stock 15400 Indirect
Common Stock 15400 Indirect
Common Stock 15400 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option to purchase common stock $549.83 2032-02-03 Common Stock (29564) 29564 Direct
Premium option to purchase common stock $1000 2035-01-31 Common Stock (36846) 36846 Direct
Premium option to purchase common stock $1100 2035-01-31 Common Stock (40780) 40780 Direct
Premium option to purchase common stock $1200 2035-01-31 Common Stock (44920) 44920 Direct

Footnotes

F1: Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 42,193 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.